Niro Ph.D Ramachandran
Chief Business Officer · Akoya Biosciences, Inc.
Individual
- 2024
- Jul 8, 2025
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Niro Ph.D Ramachandran's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Niro Ph.D Ramachandran?
Niro Ph.D Ramachandran is a corporate insider, tracked as Chief Business Officer of Akoya Biosciences, Inc. (AKYA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Niro Ph.D Ramachandran last file a Form 4?
The most recent primary Form 4 on record is dated 8 July 2025, one of 2 filings going back to 2024.
